ABBOTT LABORATORIES Annual Net Income (Loss) Attributable to Parent in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Abbott Laboratories quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2011 to 2023.
  • Abbott Laboratories Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $1.65B, a 14.6% increase year-over-year.
  • Abbott Laboratories Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $5.77B, a 11.7% increase year-over-year.
  • Abbott Laboratories annual Net Income (Loss) Attributable to Parent for 2023 was $5.72B, a 17.5% decline from 2022.
  • Abbott Laboratories annual Net Income (Loss) Attributable to Parent for 2022 was $6.93B, a 1.95% decline from 2021.
  • Abbott Laboratories annual Net Income (Loss) Attributable to Parent for 2021 was $7.07B, a 57.3% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5.72B -$1.21B -17.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-16
2022 $6.93B -$138M -1.95% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-16
2021 $7.07B +$2.58B +57.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-16
2020 $4.5B +$808M +21.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-17
2019 $3.69B +$1.32B +55.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-18
2018 $2.37B +$1.89B +396% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-19
2017 $477M -$923M -65.9% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-21
2016 $1.4B -$3.02B -68.3% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-22
2015 $4.42B +$2.14B +93.7% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-16
2014 $2.28B -$292M -11.3% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-17
2013 $2.58B -$3.39B -56.8% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-19
2012 $5.96B +$1.24B +26.1% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-27
2011 $4.73B Jan 1, 2011 Dec 31, 2011 10-K 2014-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.